Scientific content is reviewed against source materials throughout production, not only at final delivery. Every visual element, including molecular representations, cellular processes, and clinical figures, is built from reviewed scientific references. For pharmaceutical and medical affairs content, accuracy at every stage is not optional. We identify and resolve scientific discrepancies before the animation is finalized.

Yes. Scientific explainer videos are frequently produced in parallel versions: one structured for healthcare professionals with full clinical and mechanistic detail, and a second structured for patients, caregivers, or investors with the same core science simplified for a non-specialist audience. We design the communication structure to support this from the start of the project.

Both, depending on the context. For congress or advisory board use, a scientific explainer video is built to support live discussion, not replace it, with cleaner pacing and visual cues that follow a presenter's flow. It also works as standalone content for HCP education or disease awareness, where it needs to communicate the full message on its own without a presenter in the room.

Yes. Because we build every scientific explainer video as an editable PowerPoint file, healthcare teams can revise content, update clinical data, and export a new version without returning to a production agency. Indication expansions, label updates, and messaging changes across markets are all manageable within the original source file. No rebuilding required.

AI tools can generate visuals quickly but cannot validate scientific accuracy, manage medical review workflows, or build explainer videos around a specific communication objective. We do all three, working from reviewed scientific content through to a finished video built for your audience and communication goal.

o. Every visual, diagram, and layout is built from scratch for your project. We do not use stock illustration libraries or third-party template assets in materials delivered to pharmaceutical and medical affairs teams. All files are original and cleared for use in regulated healthcare environments.

Timelines depend on scientific complexity, review requirements, and delivery format, and we confirm a clear schedule at brief stage. Our medical design team can work within tight deadlines when needed, though we always recommend a timeline that allows proper scientific review. This protects accuracy and gives the final video the best chance of working well for HCP education, congress communication, or product launch.

A mechanism of action animation shows how a therapy works at a molecular or cellular level. A mechanism of disease animation shows how a condition develops or progresses. Medical affairs and pharmaceutical brand teams often need both within the same communication program, depending on whether the goal is to explain the treatment, the disease, or both.

Yes. We work with pharmaceutical companies, biotech teams, medical affairs departments and life sciences organizations across Europe, USA, and Asia, including teams preparing for FDA advisory committee meetings, EMA submissions, international medical congresses, and national physician education programs. All projects are managed remotely with no impact on timelines or quality.

We do not work with freelancers, since accuracy and confidentiality both depend on a consistent, accountable team. All of our designers are medically graduated, with a genuine interest in scientific storytelling, not general motion designers working from a script alone. This means mechanism of action, clinical data, and disease pathways are interpreted correctly before any visual work begins, so the science is accurate from the first draft rather than corrected after the fact.